Dahl Jordi S, Eleid Mackram F, Michelena Hector I, Scott Christopher G, Suri Rakesh M, Schaff Hartzell V, Pellikka Patricia A
From the Division of Cardiovascular Diseases (J.S.D., M.F.E., H.I.M., P.A.P.), Division of Biostatistics (C.G.S.), and Division of Cardiovascular Surgery (R.M.S., H.V.S.), Mayo Clinic, Rochester, MN.
Circ Cardiovasc Imaging. 2015 Apr;8(4). doi: 10.1161/CIRCIMAGING.114.002917.
In asymptomatic patients with severe aortic stenosis, guidelines recommend left ventricular ejection fraction (LVEF) of <50% as the threshold for referral for aortic valve replacement. We investigated the importance of LVEF on long-term outcome after aortic valve replacement in symptomatic and asymptomatic patients with severe aortic stenosis.
We retrospectively identified 2017 patients with severe aortic stenosis (aortic valve area<1 cm(2), mean gradient≥40 mm Hg, or indexed aortic valve area<0.6 cm(2)/m(2)) who underwent surgical aortic valve replacement from January 1995 to June 2009. Patients were divided into 4 groups depending on preoperative LVEF (<50% in 300 [15%] patients, 50%-59% in 331 [17%], 60%-69% in 908 [45%], and ≥70% in 478 [24%]). During follow-up of 5.3±4.4 years, 1056 (52%) patients died. A decrease in mortality was observed with increasing LVEF, P<0.0001; 5-year mortality estimates (95% confidence interval) were 0.41 (0.35-0.47), LVEF<50%; 0.35 (0.29-0.41), LVEF 50% to 59%; 0.26 (0.23-0.29), LVEF 60% to 69%; and 0.22 (0.18-0.26), LVEF≥70%. Compared with patients with LVEF≥60%, patients with LVEF 50% to 59% had increased mortality (hazard ratio [HR], 1.58; P<0.001), with similar risk increase in both symptomatic (HR, 1.56; P<0.001) and asymptomatic patients (HR, 1.58; P=0.006). Correcting for risk factors, LV mass index, aortic valve area, and stroke volume index, LVEF was independently predictive of mortality (HR, 0.88 per 10%; P<0.001). When this analysis was repeated in the subset of 1333 patients without history of coronary artery disease, LVEF remained associated with mortality (HR, 0.90 per 10%; P=0.009).
LVEF is a powerful predictor of outcome in patients with severe aortic stenosis undergoing aortic valve replacement, independent of the presence of valve-related symptoms.
对于无症状的严重主动脉瓣狭窄患者,指南推荐将左心室射血分数(LVEF)<50%作为转诊进行主动脉瓣置换的阈值。我们研究了LVEF对有症状和无症状的严重主动脉瓣狭窄患者主动脉瓣置换术后长期预后的重要性。
我们回顾性纳入了1995年1月至2009年6月期间接受外科主动脉瓣置换术的2017例严重主动脉瓣狭窄患者(主动脉瓣面积<1 cm²,平均压力阶差≥40 mmHg,或体表面积校正后的主动脉瓣面积<0.6 cm²/m²)。根据术前LVEF将患者分为4组(300例[15%]患者LVEF<50%,331例[17%]患者LVEF为50%-59%,908例[45%]患者LVEF为60%-69%,478例[24%]患者LVEF≥70%)。在5.3±4.4年的随访期间,1056例(52%)患者死亡。随着LVEF升高,死亡率降低,P<0.0001;5年死亡率估计值(95%置信区间)分别为:LVEF<50%组为0.41(0.35-0.47);LVEF 50%至59%组为0.35(0.29-0.41);LVEF 60%至69%组为0.26(0.23-0.29);LVEF≥70%组为0.22(0.18-0.26)。与LVEF≥60%的患者相比,LVEF为50%至59%的患者死亡率增加(风险比[HR],1.58;P<0.001),有症状患者(HR,1.56;P<0.001)和无症状患者(HR,1.58;P=0.006)的风险增加相似。校正风险因素、左心室质量指数、主动脉瓣面积和每搏量指数后,LVEF是死亡率的独立预测因素(HR,每10%降低0.88;P<0.001)。在1333例无冠心病病史的患者亚组中重复该分析时,LVEF仍与死亡率相关(HR,每10%降低0.90;P=0.009)。
LVEF是严重主动脉瓣狭窄患者接受主动脉瓣置换术后预后的有力预测指标,与瓣膜相关症状的有无无关。